Real-time Intraoperative Breast Cancer Visualization for Margin Assessment

Stopped Before LS301's licensing and reformulation, 9 patients received LS301-HSA (Phase 1a) , but since no patients were recruited (in Phase 1b) before the product expired, this study has been terminated.

Conditions

• Breast Cancer
• Cancer of the Breast

Interventions

• DRUG: LS301
• DEVICE: Cancer Vision Goggles and standard fluorescence imaging systems
• PROCEDURE: Surgery

Sponsor

Samuel Achilefu